Evidence map›Paper›PMID 32516630›Full record

ArticleParkinsonism & related disorders2020

The impact of supine hypertension on target organ damage and survival in patients with synucleinopathies and neurogenic orthostatic hypotension.

Jose-Alberto Palma, Gabriel Redel-Traub, Angelo Porciuncula, Daniela Samaniego-Toro, Patricio Millar Vernetti, Yvonne W Lui, Lucy Norcliffe-Kaufmann, Horacio Kaufmann

Open access · greenAbstract read
In one paragraph

Article in Parkinsonism & related disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trial.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2021
    Trial
  3. Article
  4. Towards the Prevention of Freezing of Gait in Parkinson's Disease.The European journal of neuroscience · 2026
    Review
  5. Cardiovascular pharmacology of dopaminergic agents in humans: a review.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2026
    Review
  6. Article
  7. Article
  8. Observational
  9. Article
  10. How to treat cardiovascular autonomic failure in Parkinson's disease.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. A reset on our reclined position-a call to prioritize neurogenic supine hypertension in the synucleinopathies.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2025
    Review
  18. Approaches for treating cardiovascular symptoms in Parkinson's disease.Therapeutic advances in neurological disorders · 2025
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Jose-Alberto PalmaDepartment of Neurology, Dysautonomia Center, New York University School of Medicine, New York, NY, USA. Electronic address: josealberto.palmacarazo@nyulangone.org.
Gabriel Redel-TraubDepartment of Neurology, Dysautonomia Center, New York University School of Medicine, New York, NY, USA.
Angelo PorciunculaDepartment of Neurology, Dysautonomia Center, New York University School of Medicine, New York, NY, USA.
Daniela Samaniego-ToroDepartment of Neurology, Dysautonomia Center, New York University School of Medicine, New York, NY, USA; Department of Neurology, Hospital Universitario German Trias i Pujol, Badalona, Barcelona, Spain.
Patricio Millar VernettiDepartment of Neurology, Dysautonomia Center, New York University School of Medicine, New York, NY, USA.
Yvonne W LuiDivision of Neuroradiology, Department of Radiology, New York University School of Medicine, New York, NY, USA.
Lucy Norcliffe-KaufmannDepartment of Neurology, Dysautonomia Center, New York University School of Medicine, New York, NY, USA.
Horacio KaufmannDepartment of Neurology, Dysautonomia Center, New York University School of Medicine, New York, NY, USA. Electronic address: Horacio.Kaufmann@nyulangone.org.
Dysautonomia Foundation · USNew York University · US

Funding

Training CoreU54NS065736 · NINDS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BIAGGIONI, ITALO · 2009 to 2018
$11.6M
A futility trial of sirolimus in multiple system atrophyR01NS107596 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KAUFMANN, HORACIO, PALMA CARAZO, JOSE ALBERTO · 2018 to 2020
$2.4M
NINDS NIH HHS R01 NS107596NINDS NIH HHS U54 NS065736
6 · The paper itself

Abstract

introductionIn addition to neurogenic orthostatic hypotension (nOH), patients with synucleinopathies frequently have hypertension when supine. The long-term consequences of both abnormalities are difficult to disentangle. We aimed to determine if supine hypertension is associated with target organ damage and worse survival in patients with nOH.

methodsPatients with nOH due to multiple system atrophy (MSA), Parkinson disease (PD), or pure autonomic failure (PAF) were classified into those with or without supine hypertension (systolic BP of at least 140 mmHg or diastolic BP of at least 90 mmHg). Organ damage was assessed by measuring cerebral white matter hyperintensities (WMH), left ventricular hypertrophy (LVH), and renal function. We prospectively followed patients for 30 months (range: 12-66 months) and recorded incident cardiovascular events and all-cause mortality.

resultsFifty-seven patients (35 with probable MSA, 14 with PD and 8 with PAF) completed all evaluations. In addition to nOH (average fall 35 ± 21/17 ± 14 mmHg, systolic/diastolic, mean ± SD), 38 patients (67%) had supine hypertension (systolic BP > 140 mmHg). Compared to those without hypertension, patients with hypertension had higher blood urea nitrogen levels (P = 0.005), lower estimated glomerular filtration rate (P = 0.008), higher prevalence of LVH (P = 0.040), and higher WMH volume (P = 0.019). Longitudinal follow-up of patients for over 2 years (27.1 ± 14.5 months) showed that supine hypertension was independently associated with earlier incidence of cardiovascular events and death (HR = 0.25; P = 0.039).

conclusionsSupine hypertension in patients with nOH was associated with an increased risk for target organ damage, cardiovascular events, and premature death. Defining management strategies and safe blood pressure ranges in patients with nOH remains an important research question.

Indexed as

Autonomic Nervous System DiseasesHypertensionSynucleinopathiesAgedAged, 80 and overFemaleHeart VentriclesHumansHypotension, OrthostaticKidneyLongitudinal StudiesMaleWhite MatterAutonomic failureHypertensionMortalityOrgan damageOrthostatic hypotensionSurvival

Identifiers

PMID32516630
PMCPMC7415666
OpenAlexW3027805579

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.